TY - JOUR AU - Stel, V. S. AU - Zoccali, C. AU - Dekker, F. W. AU - Jager, K. J. PY - 2009 DA - 2009// TI - The randomized controlled trial JO - Nephron Clin Pract VL - 113 UR - https://doi.org/10.1159/000237143 DO - 10.1159/000237143 ID - Stel2009 ER - TY - JOUR AU - Rothwell, P. M. PY - 2006 DA - 2006// TI - Factors that can affect the external validity of randomised controlled trials JO - PLoS Clin Trials VL - 1 UR - https://doi.org/10.1371/journal.pctr.0010009 DO - 10.1371/journal.pctr.0010009 ID - Rothwell2006 ER - TY - JOUR AU - Henley, D. B. AU - Dowsett, S. A. AU - Chen, Y. F. AU - Liu-Seifert, H. AU - Grill, J. D. AU - Doody, R. S. PY - 2015 DA - 2015// TI - Alzheimer's disease progression by geographical region in a clinical trial setting JO - Alzheimers Res Ther VL - 7 UR - https://doi.org/10.1186/s13195-015-0127-0 DO - 10.1186/s13195-015-0127-0 ID - Henley2015 ER - TY - JOUR AU - Grill, J. D. AU - Raman, R. AU - Ernstrom, K. AU - Aisen, P. AU - Dowsett, S. A. AU - Chen, Y. F. PY - 2015 DA - 2015// TI - Comparing recruitment, retention, and safety reporting among geographic regions in multinational Alzheimer’s disease clinical trials JO - Alzheimers Res Ther VL - 7 UR - https://doi.org/10.1186/s13195-015-0122-5 DO - 10.1186/s13195-015-0122-5 ID - Grill2015 ER - TY - JOUR AU - Wimo, A. AU - Reed, C. C. AU - Dodel, R. AU - Belger, M. AU - Jones, R. W. AU - Happich, M. PY - 2013 DA - 2013// TI - The GERAS study: a prospective observational study of costs and resource use in Alzheimer’s disease of community dwellers in three European countries—study design and baseline findings JO - J Alzheimers Dis VL - 36 ID - Wimo2013 ER - TY - JOUR AU - Doody, R. S. AU - Thomas, R. G. AU - Farlow, M. AU - Iwatsubo, T. AU - Vellas, B. AU - Joffe, S. PY - 2014 DA - 2014// TI - Alzheimer's Disease Cooperative Study Steering Committee; Solanezumab Study Group. Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease JO - N Engl J Med VL - 370 UR - https://doi.org/10.1056/NEJMoa1312889 DO - 10.1056/NEJMoa1312889 ID - Doody2014 ER - TY - STD TI - Siemers ER, Sundell KL, Carlson C, Case M, Sethuraman G, Liu-Seifert H, et al. Phase 3 solanezumab trials: secondary outcomes in mild Alzheimer's disease patients. Alzheimers Dement. 2016;12:110–20. https://doi.org/10.1016/j.jalz.2015.06.1893. Epub 2015 Aug 1. ID - ref7 ER - TY - JOUR AU - McKhann, G. AU - Drachman, D. AU - Folestein, M. AU - Katzman, R. AU - Price, D. AU - Stadlan, E. M. PY - 1984 DA - 1984// TI - Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease JO - Neurology VL - 34 UR - https://doi.org/10.1212/WNL.34.7.939 DO - 10.1212/WNL.34.7.939 ID - McKhann1984 ER - TY - JOUR AU - Folstein, M. F. AU - Folstein, S. E. AU - McHugh, P. R. PY - 1975 DA - 1975// TI - ‘Mini-mental state.’ A practical method for grading the cognitive state of patients for the clinician JO - J Psychiatr Res VL - 12 UR - https://doi.org/10.1016/0022-3956(75)90026-6 DO - 10.1016/0022-3956(75)90026-6 ID - Folstein1975 ER - TY - STD TI - National Institute for Health and Care Excellence. Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease. Technology Appraisal Guidance TA 217. London: NICE; 2011. https://www.nice.org.uk/guidance/ta217 UR - https://www.nice.org.uk/guidance/ta217 ID - ref10 ER - TY - JOUR AU - Rosen, W. G. AU - Mohs, R. C. AU - Davis, K. L. PY - 1984 DA - 1984// TI - A new rating scale for Alzheimer's disease JO - Am J Psychiatry VL - 141 UR - https://doi.org/10.1176/ajp.141.11.1356 DO - 10.1176/ajp.141.11.1356 ID - Rosen1984 ER - TY - STD TI - Mohs RC, Knopman D, Petersen RC, Ferris SH, Ernesto C, Grundman M, et al. Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer’s Disease Assessment Scale that broaden its scope. The Alzheimer’s Disease Cooperative Study. Alzheimer Dis Assoc Disord. 1997;11(Suppl 2):S13–21. ID - ref12 ER - TY - JOUR AU - Galasko, D. AU - Bennett, D. AU - Sano, M. AU - Ernesto, C. AU - Thomas, R. AU - Grundman, M. PY - 1997 DA - 1997// TI - and the ADCS. An inventory to assess activities of daily living for clinical trials in Alzheimer's disease JO - Alzheimer Dis Assoc Disord VL - 11 UR - https://doi.org/10.1097/00002093-199700112-00005 DO - 10.1097/00002093-199700112-00005 ID - Galasko1997 ER - TY - JOUR AU - Cummings, J. L. AU - Mega, M. AU - Gray, K. AU - Rosenberg-Thompson, S. AU - Carusi, D. A. AU - Gornbein, J. PY - 1994 DA - 1994// TI - The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia JO - Neurology VL - 44 ID - Cummings1994 ER - TY - JOUR AU - Cummings, J. L. PY - 1997 DA - 1997// TI - The neuropsychiatric inventory: assessing psychopathology in dementia patients JO - Neurology VL - 48 UR - https://doi.org/10.1212/WNL.48.5_Suppl_6.10S DO - 10.1212/WNL.48.5_Suppl_6.10S ID - Cummings1997 ER - TY - CHAP AU - Kind, P. ED - Spiker, B. PY - 1996 DA - 1996// TI - The EuroQol instrument: an index of health-related quality of life BT - Quality of life and pharmacoeconomics in clinical trials PB - Lippincott-Raven CY - Philadelphia ID - Kind1996 ER - TY - CHAP AU - Wimo, A. AU - Wetterholm, A. L. AU - Mastey, V. AU - Winblad, B. ED - Wimo, A. ED - Jönsson, B. ED - Karlsson, G. ED - Winblad, B. PY - 1998 DA - 1998// TI - Evaluation of the healthcare resource utilization and caregiver time in anti-dementia drug trials BT - Health economics of dementia PB - Sons CY - London ID - Wimo1998 ER - TY - JOUR AU - Rubin, D. B. PY - 2004 DA - 2004// TI - On principles for modeling propensity scores in medical research JO - Pharmacoepidemiol Drug Saf VL - 13 UR - https://doi.org/10.1002/pds.968 DO - 10.1002/pds.968 ID - Rubin2004 ER - TY - CHAP AU - Faries, D. E. AU - Leon, A. C. AU - Haro, J. M. AU - Obenchain, R. L. PY - 2010 DA - 2010// TI - Propensity score stratification and regression BT - Analysis of observational health care data using SAS PB - SAS Institute Inc CY - Cary, NC ID - Faries2010 ER - TY - STD TI - Barrett A, Belger M, Dell’Agnello G, Kahle-Wrobleski K, Sethuraman G, Henley D, et al. Representativeness of clinical trial populations in mild Alzheimer’s disease dementia—a comparison of 18-month outcomes with real-world data from the GERAS observational study [poster presentation]. Clinical Trials on Alzheimer’s Disease (CTAD) 8th Annual Meeting; 2015 Nov 5–7; Barcelona. JPAD. 2:123 [abstract P3–16]. ID - ref20 ER -